search
search
Search forecasts by ticker or company
emoji_events
Our track record
bedtime
RGEN
REPLIGEN CORP
Healthcare
|
Mid
Cap
$0.35
EPS Forecast
$155.2
Revenue Forecast
close
Announcing earnings for the quarter ending 2024-09-30 soon
Earnings forecasts
Stock price predictions
Historical data
Comparable companies
Edgar report
REPL
Replimune Group Inc
TECH
Bio-techne Corp
CRSP
Crispr Therapeutics Ag
DNLI
Denali Therapeutics Inc
HALO
Halozyme Therapeutics Inc
IOVA
Iovance Biotherapeutics Inc
NBIX
Neurocrine Biosciences Inc
NVAX
Novavax Inc
MRNA
Moderna Inc